Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis.

Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S, Nakamura Y.

Hum Genet. 1996 May;97(5):625-31.

PMID:
8655143
2.

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

Matsuoka S, Thompson JS, Edwards MC, Bartletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP.

Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3026-30.

3.
4.

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.

Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ.

Genes Dev. 1995 Mar 15;9(6):650-62.

5.

Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.

Hatada I, Mukai T.

Nat Genet. 1995 Oct;11(2):204-6.

PMID:
7550351
6.

Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.

O'Keefe D, Dao D, Zhao L, Sanderson R, Warburton D, Weiss L, Anyane-Yeboa K, Tycko B.

Am J Hum Genet. 1997 Aug;61(2):295-303.

7.

Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing.

Katagiri T, Harada Y, Emi M, Nakamura Y.

Cytogenet Cell Genet. 1995;68(1-2):39-44.

PMID:
7956356
8.

Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas.

Ferrando AA, Balbín M, Pendás AM, Vizoso F, Velasco G, López-Otín C.

Hum Genet. 1996 Jan;97(1):91-4.

PMID:
8557269
9.

Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay.

Reid LH, Crider-Miller SJ, West A, Lee MH, Massagué J, Weissman BE.

Cancer Res. 1996 Mar 15;56(6):1214-8.

10.

Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.

Shin JY, Kim HS, Lee KS, Kim J, Park JB, Won MH, Chae SW, Choi YH, Choi KC, Park YE, Lee JY.

Exp Mol Med. 2000 Jun 30;32(2):79-83.

11.

p27/Kip1 mutation found in breast cancer.

Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP.

Cancer Res. 1996 May 15;56(10):2400-4.

12.

Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.

Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massagué J, Weissman BE, Cordón-Cardó C.

Cancer Res. 1996 Mar 15;56(6):1219-21.

14.

Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.

Lai S, Goepfert H, Gillenwater AM, Luna MA, El-Naggar AK.

Clin Cancer Res. 2000 Aug;6(8):3172-6.

15.

Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.

Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C.

Biochem Biophys Res Commun. 1998 Jun 9;247(1):146-53.

PMID:
9636670
16.

p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.

Overall ML, Spencer J, Bakker M, Dziadek M, Smith PJ.

Genes Chromosomes Cancer. 1996 Sep;17(1):56-9.

PMID:
8889507
17.

Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.

Kondo M, Matsuoka S, Uchida K, Osada H, Nagatake M, Takagi K, Harper JW, Takahashi T, Elledge SJ, Takahashi T.

Oncogene. 1996 Mar 21;12(6):1365-8.

PMID:
8649840
18.

Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.

Gaston V, Le Bouc Y, Soupre V, Vazquez MP, Gicquel C.

Horm Res. 2000;54(1):1-5.

PMID:
11182628
19.

Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1392-7.

20.

P57 (KIP2) polymorphisms and breast cancer risk.

Li Y, Millikan RC, Newman B, Conway K, Tse CK, Liu ET.

Hum Genet. 1999 Jan;104(1):83-8.

PMID:
10071197

Supplemental Content

Support Center